Interestingly, we also detected a reduction of the exhaustion marker PD-1 on the total CD8 T cells in the CAR-LV treated group compared to GFP-LV group indicating that the CD8 T cells in the tumor regained their effector potential. Here, CD8A is linked to neoplasm.